Cullinan Oncology

12 Decision Makers Β· 12 Verified Contacts & Email Format

πŸ“ Cambridge, MAPharmaceuticalsπŸ—“ Est. 2017πŸ‘₯ 11–50 employees

About Cullinan Oncology

Cullinan Oncology is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

Email Format

{first_letter_first_name}{last_name}@cullinanoncology.com β€” 100.0%

ssmith@cullinanoncology.com

Leadership & Decision Makers

Contact details of 12 Cullinan Oncology decision makers

Corinne Savill

Chief Business Officer LinkedIn
  • Work email

    c*****l@cullinanoncology.com

Nadim Ahmed

President and CEO LinkedIn
  • Work email

    n****d@cullinanoncology.com

Jennifer Michaelson

Chief Development Officer LinkedIn
  • Work email

    j*********n@cullinanoncology.com

Leslie Mariani

Vice President, Finance and Operations LinkedIn
  • Work email

    l******i@cullinanoncology.com

Jeffrey Trigilio

Chief Financial Officer LinkedIn
  • Work email

    j*******o@cullinanoncology.com

Sal Firicano

VP and Head of Information Technology LinkedIn
  • Work email

    s*******o@cullinanoncology.com

Jon Wigginton

Chairman SAB and Senior Advisor

Mark Melville

Vice President

Leigh Zawel

Chief Scientific Officer

K. Dane Wittrup

Co-founder, Cullinan Amber LLC

Patrick Baeuerle

CSO & Co-Founder

Jacquelyn Sumer

Chief Legal Officer, Corporate Secretary, Chief Compliance Officer

General Emails

General company emails, e.g. customer support lines

    info@cullinoncology.com

    General Inquiries

    contact@cullinanoncology.com

    General Inquiries

    klagueerre@cullinanoncology.com

    Unclassified inbox

    u003erhickey@cullinanoncology.com

    Unclassified inbox

    privacy@cullinanoncology.com

    Unclassified inbox

    filn@cullinanoncology.com

    Unclassified inbox

Similar Companies like Cullinan Oncology

Moderna

modernatx.com
Biotechnology Β· Cambridge, MA Β· Est. 2010 Β· 1001–5000 employees

HQ: Cambridge, MA

Deep Science Ventures

deepscienceventures.com
Pharmaceuticals Β· London, England, United Kingdom Β· Est. 2016 Β· 11–50 employees

HQ: London, England, United Kingdom

Eagle Pharmaceuticals

eagleus.com
Biotechnology Β· Woodcliff Lake, New Jersey, United States Β· Est. 2007 Β· 101–250 employees

HQ: Woodcliff Lake, New Jersey, United States

Loxo Oncology

loxooncology.com
Pharmaceuticals Β· New York, NY Β· Est. 2013 Β· 501–1000 employees

HQ: New York, NY

Debiopharm Group

debiopharm.com
Biotechnology Β· Lausanne, Vaud, Switzerland Β· Est. 1979 Β· 501–1000 employees Β· $50M–$100M

HQ: Lausanne, Vaud, Switzerland

Explore similar firms in the Pharmaceuticals sector

Company Info

Last updated: 27/07/2025

Cambridge, MA

Specialization: Biopharmaceutical, Oncology,
Legal Name: Cullinan Oncology LLC
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Founded Date: 2017
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CGEM
Operating Status: Active
Last Funding Type: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Investments Activity: Mar 14, 2024 Mar 14, 2024 Feb 27, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.